JULIE BICHELMEYER: Open Payments
NPI 1578100509 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 35 payments from 11 companies in 2025. Trend: 2023 $928 · 2024 $1,022 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $144 |
| Alnylam Pharmaceuticals Inc. | 5 | $84 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $58 |
| Novo Nordisk Inc | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
| Novartis Pharmaceuticals Corporation | 3 | $49 |
| Amgen Inc. | 3 | $45 |
| PFIZER INC. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Philips North America LLC | 1 | $14 |
Products named: ELIQUIS, ONPATTRO, CAMZYOS, LifeVest, Wegovy, JARDIANCE, LEQVIO, REPATHA.
Industry payments across KS — which companies pay providers there.
